Ohio Admin. Code 4729:5-5-26 - [Effective 6/30/2025] Outpatient pharmacy delivery services
(A)
As used in this
rule:
(1)
"Business day" means any day, excluding holidays, where the
pharmacy is open for business.
(2)
"Common carrier"
means a person holding itself out to the general public to provide
transportation for compensation.
(3)
"Contract
carrier" means a person providing transportation for compensation under
continuing agreements with one person or a limited number of
persons.
(4)
"Pharmacy delivery agent" means the United States
postal service or common carrier, contract carrier, or employee of the terminal
distributor of dangerous drugs who delivers dangerous drugs that have been
dispensed to a patient or agent of the patient.
(5)
"Temperature
sensitive drug" means any drug that is required to be stored at temperatures
outside of controlled room temperature (fifty-nine degrees Fahrenheit to
eighty-six degrees Fahrenheit).
(B)
An outpatient
pharmacy licensed as a terminal distributor of dangerous drugs providing
delivery services of dispensed drugs and devices in this state shall comply
with the following:
(1)
Contact the patient or patient's caregiver for consent
prior to any billing or delivery of a drug or device, except if the patient has
provided general consent for delivery services. Consent may be provided in
writing, electronically, or verbally. In lieu of contacting the patient or
patient's caregiver to obtain consent, the pharmacy shall provide a refund if
the patient or patient's caregiver notifies the pharmacy that a dispensed drug
or device was unneeded or unwanted.
(2)
In accordance
with the patient's communication preferences, make available to the patient or
patients caregiver the date shipped, method of delivery (e.g., mail, courier,
drone, etc.), and expected arrival. This information can be provided by
electronic, telephonic, or any other manner that allows the patient to access
the information required pursuant to this paragraph.
(3)
Take all
appropriate measures to ensure that temperature sensitive drugs will be
maintained within the temperature ranges recommended by the manufacturer until
the delivery has been completed.
(4)
If the patient's
prescription is a temperature sensitive drug, provide notification to the
patient of the timeliness in addressing proper storage of the
medication.
(5)
Arrange for any controlled substances to require proof
of delivery, which may include the signature of the receiving
party.
(6)
Assist patients with arranging access to medication
from a local pharmacy if unable to deliver medications in the expected
timeframe.
(7)
Provide a method by which the patient or patient's
caregiver can notify the pharmacy as to any irregularity in the delivery of the
drug or device, including all of the following:
(a)
Timeliness of
delivery.
(b)
Condition of the drug or device upon
delivery.
(c)
Failure to receive the proper drug or
device.
(8)
Ensure there is a process to inform the patient or
patient's caregiver within two business days of being notified of the delay if
the scheduled delivery of the patient's prescription will be interrupted or
late.
(C)
Upon notification of the dispensing pharmacy by the
patient or patient's caregiver, any drug or device which is compromised or lost
in transit shall be replaced at no additional cost to the patient. If the
timeliness of the replacement will lead to an interruption in therapy, the
outpatient pharmacy shall take all available steps to mitigate patient
harm.
(D)
Any drug or device that has been delivered to a patient
or is no longer in the possession of a pharmacy delivery agent shall not be
returned to stock in accordance with rule
4729:5-5-22 of the
Administrative Code.
(E)
An outpatient pharmacy shall maintain the following
records for all drugs and devices delivered in accordance with this rule:
(1)
Patient
name;
(2)
Patient address;
(3)
Prescription
number of drug or device being delivered;
(4)
Name (brand name
or generic) and dosage of each drug or device being delivered;
(5)
Name of the
pharmacy delivery agent who performed, or attempted to perform, the delivery as
follows:
(a)
For
the United State postal service (USPS) or a common carrier, the record shall
indicate either the USPS or the name of the common carrier.
(b)
For a contract
carrier, the record shall indicate the name of the contract carrier and the
individual conducting the delivery on behalf of the contract
carrier.
(c)
For an employee of the terminal distributor of
dangerous drugs, the record shall include the full name of the
employee.
(F)
All records
maintained in accordance with this rule shall be readily retrievable and
uniformly maintained for a period of three years.
(G)
Except for
deliveries performed by the United States postal service or common carrier, an
outpatient pharmacy that utilizes a third-party to deliver drugs and devices
shall enter into a contract with the third-party to ensure the following:
(1)
The required
records in paragraph (E) of this rule are provided to the contracting pharmacy;
and
(2)
The third-party entity agrees to cooperate with all
investigations regarding the theft or significant loss of drugs and devices and
produce required records listed in paragraph (E) of this rule within three
business days of a request by an agent, officer, or employee of the
board.
(H)
Theft or significant loss of any dangerous drugs shall
be reported to the board in accordance with rule
4729:5-3-02 of the
Administrative Code.
Notes
Promulgated Under: 119.03
Statutory Authority: 4729.26
Rule Amplifies: 4729.551, 4729.54, 4729.55
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.